{
  "@type": "dcat:Dataset",
  "accessLevel": "public",
  "bureauCode": [
    "009:25"
  ],
  "contactPoint": {
    "@type": "vcard:Contact",
    "fn": "NIH/NCBI Data Team",
    "hasEmail": "mailto:info@ncbi.nlm.nih.gov"
  },
  "description": "A novel derivative of (-)-6,6-dimethylbicyclo [3.1.1] ept-2- ene-2-ethanol (J.P. Bain. J. Am. Chem. Soc. 1946, Vol. 68, page 638) is disclosed. The patent composition is marketed e.g. under the name nopol, v. The Aldrich-Europe Catalog Handbook of Fine Chemicals, item 3160-5 nopol 98% 128-50-7.The object of the present invention is the compound of formula (I) : 4-(2-hydroxyethyl) -a a dimethyl-5-hydroxy-3-cyclohexene-1-methanol, with the process for obtaining the same. which consists of the preparation of (-)-(6,6-dimethylbicyclo[3.1.1.] ept-2-ene-2-ethanol epoxide, followed by hydration of the above compound. Finally, this invention comprises the pharmaceutical compositions con- taming the compound of formula (I) which have a mucosecretolytic pharmacological activity.",
  "distribution": [
    {
      "@type": "dcat:Distribution",
      "description": "Access the complete Patent AT-E40103-T1: [Translated] CYCLOHEXENEMETHANOL DERIVATIVE WITH MUCOSECRETOLYTIC ACTIVITY, ITS MANUFACTURING PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT. on the official website.",
      "downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E40103-T1",
      "mediaType": "text/html",
      "title": "Official Data Source"
    }
  ],
  "identifier": "https://healthdata.gov/api/views/ahqd-a22j",
  "issued": "2025-09-05",
  "keyword": [
    "chemistry",
    "innovation",
    "patent",
    "pubchem",
    "research"
  ],
  "landingPage": "https://healthdata.gov/d/ahqd-a22j",
  "modified": "2025-09-06",
  "programCode": [
    "009:066"
  ],
  "publisher": {
    "@type": "org:Organization",
    "name": "National Center for Biotechnology Information (NCBI)"
  },
  "theme": [
    "NIH"
  ],
  "title": "Patent AT-E40103-T1: [Translated] CYCLOHEXENEMETHANOL DERIVATIVE WITH MUCOSECRETOLYTIC ACTIVITY, ITS MANUFACTURING PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT."
}